Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blueberries MedicalBBRRF 14-Day RSI is 48.67 as of Jul. 21, 2026. The stock has 2 warning signs investors should review. Among 1,044 Drug Manufacturers companies, Blueberries Medical ranks worse than 97.32% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for Blueberries Medical's 14-Day RSI or its related term are showing as below:
BBRRF's 14-Day RSI is ranked worse than 97.32% of 1044
companies
in the Drug Manufacturers industry
Industry Median: 48.335
vs BBRRF: 48.67
Blueberries Medical (OTCPK:BBRRF) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Blueberries Medical 14-Day RSI Related Terms
BBRRF vs ZTS, UTHR: 14-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueberries Medical 14-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Blueberries Medical's 14-Day RSI falls into.
Blueberries Medical (OTCPK:BBRRF) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blueberries Medical (BBRRF) has a 14-Day RSI of 48.67 as of Jul. 21, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Blueberries Medical and its competitors. According to the industry distribution chart, Blueberries Medical ranks #1016 out of 1044 companies in the Drug Manufacturers industry, placing it in the top 97.3%.
Is Blueberries Medical's 14-Day RSI too high?
Blueberries Medical's current 14-Day RSI is 48.67. The Drug Manufacturers industry median 14-Day RSI is 48.34. Blueberries Medical's value of 48.67 is 0.7% above this industry median. Based on the distribution chart, Blueberries Medical ranks #1016 out of 1044 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Blueberries Medical's 14-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #1016 out of 1044 companies for 14-Day RSI. This places Blueberries Medical in the lower half of its industry. The industry median 14-Day RSI is 48.34. Blueberries Medical's value of 48.67 is 0.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Drug Manufacturers company?
The median 14-Day RSI among Drug Manufacturers companies is 48.34, based on 1,044 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blueberries Medical's current 14-Day RSI of 48.67 is 0.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Blueberries Medical and its competitors. For the Drug Manufacturers industry, the median 14-Day RSI is 48.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueberries Medical's current 14-Day RSI is 48.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current 14-Day RSI of 48.67. The current 14-Day RSI is 48.67 and 0.7% above the Drug Manufacturers industry median of 48.34. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current 14-Day RSI is 48.67 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBRRF has been successfully added to your 
